Testing effectiveness (Phase 2)Ended earlyNCT01039103
What this trial is testing
Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)
Who this might be right for
Acute Exacerbation of Remitting Relapsing Multiple SclerosisClinically Isolated Syndrome
Galapagos NV 15